Wednesday, the FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with ...
Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...
We sit here today, we probably have one of the best Phase III pipelines we've had at our companies -- certainly, our recent history ... We received the approval. We're launching in Germany and Austria ...
Kremlin says Lebanon pager blasts risk igniting tensions in 'explosive' region Merck, a leading science and technology company, launched the first single-use reactor specifically designed to ...
In addition to Truist Financial, Merck & Company also received a Buy from Goldman Sachs’s Chris Shibutani in a report issued today. However, on August 29, Wells Fargo maintained a Hold rating on ...
The gross proceeds to the Company from the exercise of the Existing Warrants together with the sale of the new warrants is expected to be approximately $6.2 million. The closing of the transaction is ...